Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Preparation of gamma poly-glutamic acid/hydroxyapatite/collagen composite as the 3D-printing scaffold for bone tissue engineering.

Nguyen TT., Hu CC., Sakthivel R., Nabilla SC., Huang YW., Yu J.

Prospective Study on Cartilage Damage, published in Biomater Res (2022) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Biomater Res (2022)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
35642070
PMCID
PMC9158383
DOI
10.1186/s40824-022-00265-7
Citations
18

Abstract (original English)

Abstract Background Movement activities involving the role of articular cartilage and bones. The presence of cartilage enables bones to move over one another smoothly. However, repetitive microtrauma and ischemia as well as genetic effects can cause an osteochondral lesion. Numerous treatment methods such as microfracture, autograft, and allograft have been used, however, it possesses treatment challenges including extensive recovery time after surgery and financial burden on patients. Nowadays, tissue engineering approaches have been developed to repair bone and osteochondral defects using biomaterial implants to induce the regeneration of stem cells. Methods In this study, a collagen/γ-polyglutamate acid (PGA)/hydroxyapatite composite scaffold was fabricated using a 3D printing technique. A collagen/γ-PGA/hydroxyapatite 2D membrane was also fabricated for comparison. The scaffolds (4 layers) were designed with the size of 8 mm in diameter and 1.2 mm in thickness. The first layer was hydroxyapatite/γ-PGA and the second to fourth layers were collagen/γ-PGA. In addition, a 2D membrane was constructed from hydroxyapatite/γ-PGA and collagen/γ-PGA with a ratio of 1:3. The biocompatibility property and degradation activity were investigated for both scaffold and membrane samples. The rat bone marrow mesenchymal stem cells ( r BMSCs) and human adipose stem cells ( h ADSCs) were cultu

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research